01ANG is exploring partnerships with local hospitals to enhance its specialty drug distribution, potentially increasing revenue by 15% over the next year.
02The company is in discussions to expand its generic portfolio, targeting a 10% increase in market share within two years.
03Recent regulatory approvals for three new generic drugs could significantly enhance revenue streams, potentially adding $50M in annual sales.
04Ongoing cost-cutting measures are expected to improve gross margins by 200 basis points over the next fiscal year.
05Rising demand for affordable healthcare solutions in India
06Growth in the specialty pharmaceuticals sector
07Changes in regulatory policies affecting drug approvals in India
08Market share gains in the generic pharmaceuticals segment
